| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Bottom |
| Cognigen Corporation - Posters and Presentations : Cognigen Corporation : Clinical : Metabolism and Nutrition Disorders : Posters : Diabetes Mellitus | published Wed, Nov 7, 2007 - 10:31 EST |
| Name | Description | Page Modified |
| Model-Based Evaluations to Select and Confirm Doses in the Clinical Development of Exenatide | Presented at the 2007 ASCPT Annual Meeting, Anaheim, CA | Mon Nov 05 15:07:26 EST 2007 |
| Population Modeling to Guide Phase 3 Dose Selection for AC2993 (Synthetic Exendin-4) | Presented at the 2002 ASCPT Annual Meeting, Atlanta, GA | Fri Nov 02 13:15:24 EDT 2007 |
| Cognigen Corporation - Posters and Presentations : Cognigen Corporation : Clinical : Metabolism and Nutrition Disorders : Posters : Diabetes Mellitus | published Wed, Nov 7, 2007 - 10:31 EST |
| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Top |